Asia Pacific Antiviral Drugs Market Size to Cross USD 7.2 Billion by 2027

In terms of revenue, Asia Pacific antiviral drugs market is forecast to surpass USD 7.2 billion by 2027. Unprecedented spike in COVID-19 cases in India, China and Australia will bolster Asia Pacific antiviral drugs market share in the next few years. As of mid-March 2021, over 25 million cases were reported in Asia. Rise in hospitalization owing to the pandemic has augmented the demand for anti-viral therapeutics.

Rampant infectious diseases will bolster the adoption of antiviral drugs across the region. According to the WHO, around 87 million people had hepatitis B’s chronic carriers in China.
 
Increasing cases of hospital-acquired infections have prompted stakeholders to further the manufacturing of antiviral drugs. According to the China Center for Disease Control, around 400 people were found to be HIV positive in 2018 per day.
 
Get sample copy of this research report @ https://www.graphicalresearch.com/request/1738/sample
 
Considering the prevalence of HIV AIDS, investments in antiviral drugs will surge dramatically across the region. According to the WHO, there were around 1.25 million people living with HIV infection in China in 2018. The market revenue from the HIV AIDS segment was pegged at over USD 3.2 billion in 2020, attributed to increasing awareness pertaining to treatment therapies.
 
End-markets are likely to exhibit traction for protease inhibitors which are highly active antiretroviral therapy drug class. These inhibitors have become highly desirable for their efficaciousness in HIV treatment. Protease inhibitors have gained impetus for efficacious therapy drug, triggering R&D activities and ARV drugs production. The Asia Pacific antiviral drugs market share from the protease inhibitors segment in APAC was pegged at more than 18% in 2020 and will expand at a substantial rate in the next few years.

 
Stakeholders are expected to infuse funds in reverse transcription inhibitors on the heels of their effectiveness in the management and treatment of HIV. Rampant disease in emerging economies has fostered the adoption of reverse transcription. It is worth noting that R&D activities in nucleoside and non-nucleoside reverse transcriptase inhibitors will augur well for the industry outlook. Asia Pacific antiviral drugs market share from the reverse transcriptase inhibitors segment stood at more than 40% in 2020 and will witness an appreciable gain by 2027.
 
Market uptake of generic antiviral drugs will be noticeable owing to heightened awareness and availability of generic therapeutics. Moreover, robust government initiatives and policies to provide high-cost treatment at affordable prices to low-income group people will bode well for the industry size expansion. The market size from the generic antiviral drugs segment was valued at more than USD 1.5 billion in 2020 and will rise notably in the ensuing period.
 
Manufacturing of antiviral drugs emphasizing adult age-group will gain prominence in India and China. For instance, the WHO has joined hands with governments and other partners across the Western Pacific to prevent, test and treat hepatitis among adults. Based on share, the adult segment logged 30% in 2020 and will rise at a considerable pace through 2027.
 
Leading companies are likely to further their investments in India following the surge in COVID-19 cases and HIV AIDS. Specifically, the Minister of Health and Family Welfare introduced a new test-and-treat policy in April 2017 for rendering access to HIV treatment in the nation. India antiviral drugs market size is forecast to surpass USD 1.2 billion by 2027, partly attributed to improving healthcare facilities.
 
The China market is likely to provide revenue-boosting opportunities following the growth in government funding and infrastructural development. The mainland will further witness injection of funds in R&D activities. China antiviral drugs market revenue share was pegged at more than 16% in 2020 and will grow notably in the next few years.
 
 
Asia Pacific antiviral drugs market players in the landscape are GlaxoSmithKline, Merck & Co., AbbVie Inc., Aurobindo Pharma Ltd and Bristol-Myers & Co., among others. These companies are likely to focus on R&D activities and manufacturing developments.
 
Table of Contents (ToC) of the report:

Chapter 1   Methodology
1.1    Market definitions
1.2    Forecast assumptions
1.3    Data sources
1.3.1    Secondary
1.3.1.1    Paid sources
1.3.1.2    Unpaid sources
1.3.2    Primary

Chapter 2   Market Summary
2.1    Asia Pacific antiviral drugs market summary, 2016 – 2027
2.1.1    Country trends
2.1.2    Drug class trends
2.1.3    Indication trends
2.1.4    Type trends
2.1.5    Age group trends

Chapter 3   Market Analysis
3.1    Industry segmentation
3.2    Industry outlook, 2016 – 2027 (USD Million)
3.3    Major factor analysis
3.3.1    Drivers
3.3.1.1    Increasing prevalence of viral infections including COVID-19
3.3.1.2    Presence of pipeline products for HIV treatment
3.3.1.3    Increasing geriatric population
3.3.2    Industry pitfalls & challenges
3.3.2.1    Presence of generics
3.3.2.2    Rising awareness about preventive drugs treatment
3.3.2.3    Drug resistance
3.3.2.4    High cost of HIV and Hepatitis drug treatment
3.4    Analysis of COVID-19 impact on the industry
3.5    Porter’s analysis
3.6    Competitive review, 2020
3.7    PEST analysis

Browse complete Table of Contents (ToC) of this research report @ https://www.graphicalresearch.com/table-of-content/1738/asia-pacific-antiviral-drugs-market
 
About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Contact Us:
Parikhit B.
Corporate Sales,
Graphical Research
Phone: 1-800-986-6917

Comments

Post a Comment

Popular posts from this blog

3D Scanning Market Share, Trends, Segmentation and Registering a Strong Growth by End of 2027

Image
The 3D scanning market is projected to foresee commendable growth in coming years owing to high product usage across various application avenues such as aerospace & defense, entertainment & media, healthcare, and architecture & engineering among many others. 3D scanning refers to the process of collecting data from the physical object's surface which precisely describes the shape in terms of 3-dimensional space. 3D-based laser scanners are known to measure fine details as well as capture free-form shapes to rapidly generate precise point clouds. Just as 2D-based images are made up of pixels, 3D scans are made up of very tiny polygons or triangles. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/105 The market for 3D scanning is bifurcated into different segments in terms of product, range, component, application, and regional landscape. With respect to range, the market is classified into long range, medium range, and short ...
Read more

Network Packet Broker Market to Observe Rugged Expansion at a Top CAGR by 2028 End

Image
The network packet broker market is set to exhibit robust growth through 2028 on account of prevalent product adoption in key regions across the globe. A network packet broker refers to a technology that includes a range of monitoring tools, also known as network packets, for accessing and analyzing traffic across a network. The packet broker gathers traffic from multiple network links and filters and distributes every individual packet to the proper network monitoring tool. Through this, these brokers ensure enhanced efficacy from network monitoring & security tools by providing better data from the network. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/2930 With growing cybersecurity demands, companies are aiming to incorporate virtual traffic, and higher traffic speeds as well as greater complexity of networks have prompted them to identify effective solutions to optimize performance. The integration of network packet brokers to col...
Read more

5G Infrastructure Market Expansion Projected to Gain an Uptick During 2022-2028

Image
The 5G infrastructure market is foreseen to grow enormously through 2028 driven by exponential demand for greater bandwidth and speed capabilities. In addition, increasing government support to promote 5G deployment is primed to further fuel market growth over the forecast timeline. 5G networks provide higher speed bandwidth than existing LTE networks. During the COVID-19 outbreak, the industry witnessed a halt due to safety protocols and lockdowns. However, easing lockdown restrictions have boosted the adoption of wireless technologies, which has enhanced the focus on commercialization of the 5G infrastructure. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5258 Furthermore, governments are actively regulating easy market access to equipment for delivering telecom services at reasonable prices to customers. For instance, in May 2022, the Telecommunication Engineering Center (TEC), a technical division of the Department of Telecommunication...
Read more